Αρχική Διεθνείς Δημοσιεύσεις Διεθνείς δημοσιεύσεις

Διεθνείς δημοσιεύσεις

print
email
  Sequential vs concurrent epirubicin and docetaxel as adjuvant chemotherapy for high-risk, node-negative, early breast cancer: an interim analysis of a randomised phase III study from the Hellenic Oncology Research Group.
  Mavroudis D, Saloustros E, Boukovinas I, Papakotoulas P, Kakolyris S, Ziras N, Christophylakis C, Kentepozidis N, Fountzilas G, Rigas G, Varthalitis I, Kalbakis K, Agelaki S, Hatzidaki D, Georgoulias V.
  Br J Cancer. 2017 Jun 22. doi: 10.1038/bjc.2017.158. [Epub ahead of print]
  PMID: 28641315 [PubMed - as supplied by publisher]
 

Similar articles

  Second-line pazopanib in patients with relapsed and refractory small-cell lung cancer: a multicentre phase II study of the Hellenic Oncology Research Group.
  Koinis F, Agelaki S, Karavassilis V, Kentepozidis N, Samantas E, Peroukidis S, Katsaounis P, Hartabilas E, Varthalitis II, Messaritakis I, Fountzilas G, Georgoulias V, Kotsakis A.
  Br J Cancer. 2017 May 16. doi: 10.1038/bjc.2017.137. [Epub ahead of print]
 

PMID: 28510571 [PubMed - as supplied by publisher]

  Heterogeneity of circulating tumor cells (CTCs) in patients with recurrent small cell lung cancer (SCLC) treated with pazopanib.
  Messaritakis I, Politaki E, Plataki M, Karavassilis V, Kentepozidis N, Koinis F, Samantas E, Georgoulias V, Kotsakis A.
  Lung Cancer. 2017 Feb;104:16-23. doi: 10.1016/j.lungcan.2016.12.008.
  PMID: 28212995 [PubMed - in process]
   
  Extensive cutaneous metastases of pancreatic adenocarcinoma: a case report and review of the literature.
  Kotsantis I, Economopoulou P, Dritsakos K, Oikonomopoulos N, Bakogeorgos M, Rapti C, Kentepozidis N.
  Clin Case Rep. 2016 Dec 20;5(1):51-56. doi: 10.1002/ccr3.737.
  PMID: 28096990 [PubMed - in process] Free PMC Article
   
  Prognostic value of circulating regulatory T cell subsets in untreated non-small cell lung cancer patients.
  Kotsakis A, Koinis F, Katsarou A, Gioulbasani M, Aggouraki D, Kentepozidis N, Georgoulias V, Vetsika EK.
  Sci Rep. 2016 Dec 15;6:39247. doi: 10.1038/srep39247.
  PMID: 27976733 [Unknown status] Free Article
   
.

CAPIRI (capecitabine, irinotecan) + bevacizumab vs FOLFIRI (folinic acid, 5 fluorouracil, irinotecan) + bevacizumab for the treatment of patients with metastatic colorectal cancer (mCRC): Interim analysis for safety of a randomized phase III trial.

  Ziras N, Polyzos A, Kakolyris S, Xenidis N, Kentepozidis N, Athanasiadis A, Stergiou I, Androulakis N, Vamvakas L, Souglakos J.
  J Clin Oncol. 2008 May 20;26(15_suppl):15008.
  PMID: 27949840 [Unknown status]
   
  A multicentre phase II trial of cabazitaxel in patients with advanced non-small-cell lung cancer progressing after docetaxel-based chemotherapy.
  Kotsakis A, Matikas A, Koinis F, Kentepozidis N, Varthalitis II, Karavassilis V, Samantas E, Katsaounis P, Dermitzaki EK, Hatzidaki D, Mavroudis D, Georgoulias V.
  Br J Cancer. 2016 Sep 8. doi: 10.1038/bjc.2016.281. [Epub ahead of print]
 

PMID: 27607471 [PubMed - as supplied by publisher]

 

Dose-dense FEC followed by Docetaxel versus Docetaxel plus Cyclophosphamide as adjuvant chemotherapy in women with HER2-negative, axillary lymph node-positive early breast cancer: A multicenter randomized study by the Hellenic Oncology Research Group (HORG).
  Mavroudis D, Matikas A, Malamos N, Papakotoulas P, Kakolyris S, Boukovinas I, Athanasiadis A, Kentepozidis N, Ziras N, Katsaounis P, Saloustros E, Georgoulias V; Breast Cancer Investigators of the Hellenic Oncology Research Group (HORG), Athens, Greece.
  Ann Oncol. 2016 Aug 8. pii: mdw274. [Epub ahead of print]
  PMID: 27502729 [PubMed - as supplied by publisher]
   
  Salvage treatment with irinotecan/cisplatin versus pemetrexed/cisplatin in patients with non-small cell lung cancer pre-treated with a non-platinum-based regimen in the first-line setting: a randomized phase II study of the Hellenic Oncology Research Group (HORG).
  Kentepozidis N, Economopoulou P, Christofyllakis C, Chelis L, Polyzos A, Vardakis N, Koinis F, Vamvakas L, Katsaounis P, Kalbakis K, Nikolaou C, Georgoulias V, Kotsakis A.
  Clin Transl Oncol. 2016 Aug 4. [Epub ahead of print]
  PMID: 27492015 [PubMed - as supplied by publisher]
  Similar articles
    Biweekly Carboplatin Plus Gemcitabine as First-Line Treatment of Elderly Patients With Advanced Squamous Non-Small-cell Lung Cancer: A Multicenter Phase I-II Trial by the Hellenic Oncology Research Group.
    Karampeazis A, Vamvakas L, Kentepozidis N, Polyzos A, Chandrinos V, Rigas G, Christofyllakis C, Kotsakis A, Hatzidaki D, Pallis AG, Georgoulias V.
    Clin Lung Cancer. 2016 Jun 2. pii: S1525-7304(16)30114-0. doi: 10.1016/j.cllc.2016.05.009. [Epub ahead of print]
    PMID: 27397849 [PubMed - as supplied by publisher]
  Efficacy and tolerance of frontline bevacizumab-based chemotherapy for advanced non-small cell lung cancer patients: a multicenter, phase IV study of the Hellenic Oncology Research Group (HORG).
  Matikas A, Kentepozidis Ν, Ardavanis A, Vaslamatzis M, Polyzos A, Emmanouilides C, Katsaounis P, Koinis F, Xynogalos S, Christopoulou A, Ziras N, Tegos T, Prinarakis E, Hatzidaki D, Georgoulias V, Kotsakis A; HORG’s Lung Cancer Working Group.
  Cancer Chemother Pharmacol. 2016 Jun 22. [Epub ahead of print]
  PMID: 27335027 [PubMed - as supplied by publisher]
  Similar articles
  Management of Resistance to Crizotinib in Anaplastic Lymphoma Kinase-Positive Non-Small-cell Lung Cancer.
  Matikas A, Kentepozidis N, Georgoulias V, Kotsakis A.
  Clin Lung Cancer. 2016 Jun 2. pii: S1525-7304(16)30111-5. doi: 10.1016/j.cllc.2016.05.006. [Epub ahead of print] Review.
  PMID: 27341790 [PubMed - as supplied by publisher]
  Similar articles
. Docetaxel plus gemcitabine versus gemcitabine in elderly patients with advanced non-small cell lung cancer and use of a geriatric assessment: Lessons from a prematurely closed Hellenic Oncology Research Group randomized phase III study.
  Karampeazis A, Vamvakas L, Kotsakis A, Christophyllakis C, Kentepozidis N, Chandrinos V, Agelidou A, Polyzos A, Tsiafaki X, Hatzidaki D, Georgoulias V.
  J Geriatr Oncol. 2016 Jun 2. pii: S1879-4068(16)30053-4. doi: 10.1016/j.jgo.2016.05.002. [Epub ahead of print]
  PMID: 27264267 [PubMed - as supplied by publisher]
  Similar articles
  A phase II, open-label trial of bortezomib (VELCADE<sup>®</sup>) in combination with gemcitabine and cisplatin in patients with locally advanced or metastatic non-small cell lung cancer.
  Kontopodis E, Kotsakis A, Kentepozidis N, Syrigos K, Ziras N, Moutsos M, Filippa G, Mala A, Vamvakas L, Mavroudis D, Georgoulias V, Agelaki S.
  Cancer Chemother Pharmacol. 2016 Mar 19. [Epub ahead of print]
  PMID: 26994909 [PubMed - as supplied by publisher]
   
  Utilization of Systemic Chemotherapy in Advanced Urothelial Cancer: A Retrospective Collaborative Study by the Hellenic Genitourinary Cancer Group (HGUCG).
  Bamias A, Peroukidis S, Stamatopoulou S, Tzannis K, Koutsoukos K, Andreadis C, Bozionelou V, Pistalmatzian N, Papatsoris A, Stravodimos K, Varthalitis I, Karamouzis M, Milaki G, Agorastos A, Kentepozidis N, Androulakis N, Bompolaki I, Kalofonos H, Mavroudis D, Dimopoulos MA.
  Clin Genitourin Cancer. 2016 Apr;14(2):e153-9. doi: 10.1016/j.clgc.2015.09.009. Epub 2015 Sep 25.
  PMID: 26437909 [PubMed - in process]
  Similar articles
  Cancer therapy and cardiovascular risk: focus on bevacizumab.
  Economopoulou P, Kotsakis A, Kapiris I, Kentepozidis N.
  Cancer Manag Res. 2015 Jun 3;7:133-43. doi: 10.2147/CMAR.S77400. eCollection 2015. Review.
  PMID: 26082660 [PubMed] Free PMC Article
  Similar articles
  Six versus 12 months of adjuvant trastuzumab in combination with dose-dense chemotherapy for women with HER2-positive breast cancer: a multicenter randomized study by the Hellenic Oncology Research Group (HORG).
  Mavroudis D, Saloustros E, Malamos N, Kakolyris S, Boukovinas I, Papakotoulas P, Kentepozidis N, Ziras N, Georgoulias V; Breast Cancer Investigators of Hellenic Oncology Research Group (HORG), Athens, Greece.
  Ann Oncol. 2015 Jul;26(7):1333-40. doi: 10.1093/annonc/mdv213. Epub 2015 May 1.
  PMID: 25935793 [PubMed - in process]
  Similar articles
  Cisplatin in combination with metronomic vinorelbine as front-line treatment in advanced non-small cell lung cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG).
  Katsaounis P, Kotsakis A, Agelaki S, Kontopodis E, Agelidou A, Kentepozidis N, Vamvakas L, Christopoulou A, Karachaliou N, Hatzidaki D, Georgoulias V.
  Cancer Chemother Pharmacol. 2015 Apr;75(4):821-7. doi: 10.1007/s00280-015-2707-x. Epub 2015 Feb 22.
  PMID: 25702051 [PubMed - indexed for MEDLINE]
  Similar articles
  Sequential administration of vinorelbine plus cisplatin and bevacizumab followed by docetaxel plus gemcitabine and bevacizumab compared to docetaxel plus cisplatin and bevacizumab regimen as first-line therapy for advanced or metastatic non-squamous non-small cell lung cancer: A multicenter randomized phase II trial of the Hellenic Oncology Research Group (HORG).
  Kotsakis A, Kentepozidis N, Emmanouilidis Ch, Polyzos A, Agelidou A, Vaslamatzis M, Chandrinos V, Agelaki S, Vamvakas L, Kalbakis K, Katsaounis P, Stoltidis D, Nintos G, Hatzidaki D, Vetsika EK, Mavroudis D, Georgoulias V.
  Lung Cancer. 2015 Apr;88(1):57-62. doi: 10.1016/j.lungcan.2015.01.012. Epub 2015 Jan 23.
  PMID: 25662596 [PubMed - indexed for MEDLINE]
  Similar articles
. Do elderly patients with non-small cell lung cancer get the best out of recent advances in first-line treatment? A comparative study in two tertiary cancer centers in Greece.
  Bakogeorgos M, Mountzios G, Bournakis E, Economopoulou P, Kotsantis G, Fytrakis N, Kouvatseas G, Dimopoulos MA, Kentepozidis N.
  J Geriatr Oncol. 2015 Mar;6(2):111-8. doi: 10.1016/j.jgo.2014.11.001. Epub 2014 Dec 4.
  PMID: 25482021 [PubMed - indexed for MEDLINE]
  Similar articles
  The case of the missed chest radiograph: bilateral mammary gland metastases mimicking multifocal primary breast cancer as the initial manifestation of non-small-cell lung cancer.
  Mountzios G, Gyftopoulos A, Vlotinou E, Kentepozidis N.
  J Thorac Oncol. 2014 Nov;9(11):1729-31. doi: 10.1097/JTO.0000000000000265. No abstract available.
  PMID: 25436808 [PubMed - indexed for MEDLINE] Free Article
  Similar articles
  Dose-dense paclitaxel versus docetaxel following FEC as adjuvant chemotherapy in axillary node-positive early breast cancer: a multicenter randomized study of the Hellenic Oncology Research Group (HORG).
  Saloustros E, Malamos N, Boukovinas I, Kakolyris S, Kouroussis C, Athanasiadis A, Ziras N, Kentepozidis N, Makrantonakis P, Polyzos A, Christophyllakis C, Georgoulias V, Mavroudis D.
  Breast Cancer Res Treat. 2014 Dec;148(3):591-7. doi: 10.1007/s10549-014-3202-5. Epub 2014 Nov 16.
  PMID: 25399229 [PubMed - indexed for MEDLINE]
  Similar articles
  Docetaxel, gemcitabine and bevacizumab as salvage chemotherapy for HER-2-negative metastatic breast cancer.
  Kontopodis E, Kentepozidis N, Christophyllakis Ch, Boukovinas I, Kalykaki A, Kalbakis K, Vamvakas L, Agelaki S, Kotsakis A, Vardakis N, Georgoulias V, Mavroudis D.
  Cancer Chemother Pharmacol. 2015 Jan;75(1):153-60. doi: 10.1007/s00280-014-2628-0. Epub 2014 Nov 15.
  PMID: 25398698 [PubMed - indexed for MEDLINE]
  Similar articles
  A phase II trial evaluating the clinical and immunologic response of HLA-A2(+) non-small cell lung cancer patients vaccinated with an hTERT cryptic peptide.
  Kotsakis A, Papadimitraki E, Vetsika EK, Aggouraki D, Dermitzaki EK, Hatzidaki D, Kentepozidis N, Mavroudis D, Georgoulias V.
  Lung Cancer. 2014 Oct;86(1):59-66. doi: 10.1016/j.lungcan.2014.07.018. Epub 2014 Aug 5.
  PMID: 25130084 [PubMed - indexed for MEDLINE]
  Similar articles
  Frontline treatment with gemcitabine, oxaliplatin and erlotinib for the treatment of advanced or metastatic pancreatic cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG).
  Katopodis O, Souglakos J, Stathopoulos E, Christopoulou A, Kontopodis E, Kotsakis A, Kalbakis K, Kentepozidis N, Polyzos A, Hatzidaki D, Georgoulias V.
  Cancer Chemother Pharmacol. 2014 Aug;74(2):333-40. doi: 10.1007/s00280-014-2509-6. Epub 2014 Jun 15.
  PMID: 24930058 [PubMed - indexed for MEDLINE]
  Similar articles
  Chemotherapy compliance, tolerance and efficacy in elderly and non-elderly patients with metastatic colorectal cancer: a single institution comparative study.
  Bakogeorgos M, Mountzios G, Kotsantis G, Economopoulou P, Fytrakis N, Kentepozidis N.
  J BUON. 2013 Jul-Sep;18(3):629-34.
  PMID: 24065475 [PubMed - indexed for MEDLINE]
  Similar articles
  Adrenal incidentalomas in cancer patients are not always "innocent": a case report and review of the literature.
  Economopoulou P, Mountzios G, Kotsantis I, Bakogeorgos M, Ramfidis V, Kapiris I, Patsouris E, Kentepozidis N.
  Case Rep Med. 2013;2013:461409. doi: 10.1155/2013/461409. Epub 2013 Apr 10.
  PMID: 23662106 [PubMed] Free PMC Article
  Similar articles
  Pemetrexed versus erlotinib in pretreated patients with advanced non-small cell lung cancer: a Hellenic Oncology Research Group (HORG) randomized phase 3 study.
  Karampeazis A, Voutsina A, Souglakos J, Kentepozidis N, Giassas S, Christofillakis C, Kotsakis A, Papakotoulas P, Rapti A, Agelidou M, Agelaki S, Vamvakas L, Samonis G, Mavroudis D, Georgoulias V.
  Cancer. 2013 Aug 1;119(15):2754-64. doi: 10.1002/cncr.28132. Epub 2013 May 9.
  PMID: 23661337 [PubMed - indexed for MEDLINE] Free Article
  Similar articles
  A phase II study of metronomic oral vinorelbine administered in the second line and beyond in non-small cell lung cancer (NSCLC): a phase II study of the Hellenic Oncology Research Group.
  Kontopodis E, Hatzidaki D, Varthalitis I, Kentepozidis N, Giassas S, Pantazopoulos N, Vardakis N, Rovithi M, Georgoulias V, Agelaki S.
  J Chemother. 2013 Feb;25(1):49-55. doi: 10.1179/1973947812Y.0000000050.
  PMID: 23433445 [PubMed - indexed for MEDLINE]
  Similar articles
  Docetaxel plus cisplatin and bevacizumab for untreated patients with advanced/metastatic non-squamous non-small-cell lung cancer: a multicenter phase II study of the Hellenic Oncology Research Group.
  Kentepozidis N, Kotsakis A, Soultati A, Agelaki S, Christophylakis Ch, Agelidou M, Chelis L, Papakotoulas P, Vamvakas L, Zafiriou Z, Samonis G, Georgoulias V.
  Cancer Chemother Pharmacol. 2013 Mar;71(3):605-12. doi: 10.1007/s00280-012-2037-1. Epub 2013 Jan 22.
  PMID: 23338050 [PubMed - indexed for MEDLINE]
  Similar articles
  Paclitaxel in combination with carboplatin as salvage treatment in patients with castration-resistant prostate cancer: a Hellenic oncology research group multicenter phase II study.
  Kentepozidis N, Soultati A, Giassas S, Vardakis N, Kalykaki A, Kotsakis A, Papadimitraki E, Pantazopoulos N, Bozionellou V, Georgoulias V.
  Cancer Chemother Pharmacol. 2012 Jul;70(1):161-8. doi: 10.1007/s00280-012-1896-9. Epub 2012 Jun 3.
  PMID: 22660737 [PubMed - indexed for MEDLINE]
  Similar articles
  Randomised phase-II trial of CAPIRI (capecitabine, irinotecan) plus bevacizumab vs FOLFIRI (folinic acid, 5-fluorouracil, irinotecan) plus bevacizumab as first-line treatment of patients with unresectable/metastatic colorectal cancer (mCRC).
  Souglakos J, Ziras N, Kakolyris S, Boukovinas I, Kentepozidis N, Makrantonakis P, Xynogalos S, Christophyllakis Ch, Kouroussis Ch, Vamvakas L, Georgoulias V, Polyzos A.
  Br J Cancer. 2012 Jan 31;106(3):453-9. doi: 10.1038/bjc.2011.594. Epub 2012 Jan 12.
  PMID: 22240792 [PubMed - indexed for MEDLINE] Free PMC Article
  Similar articles
  A phase II trial of erlotinib as front-line treatment in clinically selected patients with non-small-cell lung cancer.
  Pallis AG, Voutsina A, Kentepozidis N, Giassas S, Papakotoulas P, Agelaki S, Tryfonidis K, Kotsakis A, Vamvakas L, Vardakis N, Georgoulias V.
  Clin Lung Cancer. 2012 Mar;13(2):129-35. doi: 10.1016/j.cllc.2011.08.004. Epub 2011 Oct 14.
  PMID: 22000696 [PubMed - indexed for MEDLINE]
  Similar articles
  Chemotherapy with gemcitabine, cisplatin, and docetaxel in the treatment for patients with muscle-invasive bladder cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG).
  Boukovinas I, Androulakis N, Kentepozidis N, Polyzos A, Papakotoulas P, Ziras N, Kotsakis A, Vardakis N, Karampeazis A, Markos V, Kostakopoulos A, Constantinides CA, Samonis G, Mavroudis D, Georgoulias V.
  Cancer Chemother Pharmacol. 2012 Feb;69(2):351-6. doi: 10.1007/s00280-011-1694-9. Epub 2011 Jul 12.
  PMID: 21748359 [PubMed - indexed for MEDLINE]
  Similar articles
  Docetaxel vs. vinorelbine in elderly patients with advanced non--small-cell lung cancer: a hellenic oncology research group randomized phase III study.
  Karampeazis A, Vamvakas L, Agelidou A, Kentepozidis N, Chainis K, Chandrinos V, Vardakis N, Pallis AG, Christophyllakis C, Georgoulias V.
  Clin Lung Cancer. 2011 May;12(3):155-60. doi: 10.1016/j.cllc.2011.03.015. Epub 2011 Apr 27.
  PMID: 21663857 [PubMed - indexed for MEDLINE]
  Similar articles
  A randomized phase III study of the docetaxel/carboplatin combination versus docetaxel single-agent as second line treatment for patients with advanced/metastatic non-small cell lung cancer.
  Pallis AG, Agelaki S, Agelidou A, Varthalitis I, Syrigos K, Kentepozidis N, Pavlakou G, Kotsakis A, Kontopodis E, Georgoulias V.
  BMC Cancer. 2010 Nov 19;10:633. doi: 10.1186/1471-2407-10-633.
  PMID: 21092076 [PubMed - indexed for MEDLINE] Free PMC Article
  Similar articles
  A dose-escalation study of pemetrexed and docetaxel in non-small-cell lung cancer.
  Kotsakis A, Agelaki S, Vardakis N, Stathopoulos G, Vamvakas L, Kalykaki A, Kentepozidis N, Kontopodis E, Sfakiotaki G, Mavroudis D, Georgoulias V.
  Cancer Chemother Pharmacol. 2011 Aug;68(2):415-22. doi: 10.1007/s00280-010-1508-5. Epub 2010 Nov 11.
  PMID: 21069335 [PubMed - indexed for MEDLINE]
  Similar articles
  Salvage treatment in metastatic breast cancer with weekly paclitaxel and bevacizumab.
  Polyzos A, Kalbakis K, Kentepozidis N, Giassas S, Kalykaki A, Vardakis N, Bozionelou V, Saloustros E, Kontopodis E, Georgoulias V, Mavroudis D.
  Cancer Chemother Pharmacol. 2011 Jul;68(1):217-23. doi: 10.1007/s00280-010-1475-x. Epub 2010 Oct 5.
  PMID: 20922389 [PubMed - indexed for MEDLINE]
  Similar articles
  A multicenter phase II trial with irinotecan plus oxaliplatin as first-line treatment for inoperable/metastatic cancer of the biliary tract.
  Karachaliou N, Polyzos A, Kentepozidis N, Kakolyris S, Ziras N, Vardakis N, Kalykaki A, Milaki G, Georgoulias V, Androulakis N.
  Oncology. 2010;78(5-6):356-60. doi: 10.1159/000320462. Epub 2010 Aug 26.
  PMID: 20798557 [PubMed - indexed for MEDLINE]
  Similar articles
  Second-line chemotherapy with capecitabine (Xeloda) and docetaxel (Taxotere) in previously treated, unresectable adenocarcinoma of pancreas: the final results of a phase II trial.
  Katopodis O, Polyzos A, Kentepozidis N, Giassas S, Rovithi M, Bozionelou V, Kalbakis K, Vamvakas L, Mavroudis D, Georgoulias V.
  Cancer Chemother Pharmacol. 2011 Feb;67(2):361-8. doi: 10.1007/s00280-010-1329-6. Epub 2010 Apr 29.
  PMID: 20428874 [PubMed - indexed for MEDLINE]
  Similar articles
  Randomized phase III trial comparing docetaxel plus epirubicin versus docetaxel plus capecitabine as first-line treatment in women with advanced breast cancer.
  Mavroudis D, Papakotoulas P, Ardavanis A, Syrigos K, Kakolyris S, Ziras N, Kouroussis C, Malamos N, Polyzos A, Christophyllakis C, Kentepozidis N, Georgoulias V; Breast Cancer Investigators of the Hellenic Oncology Research Group.
  Ann Oncol. 2010 Jan;21(1):48-54. doi: 10.1093/annonc/mdp498. Epub 2009 Nov 11.
  PMID: 19906761 [PubMed - indexed for MEDLINE] Free Article
  Similar articles
  Etoposide plus cisplatin followed by concurrent chemo-radiotherapy and irinotecan plus cisplatin for patients with limited-stage small cell lung cancer: A multicenter phase II study.
  Xenidis N, Kotsakis A, Kalykaki A, Christophyllakis Ch, Giassas S, Kentepozidis N, Polyzos A, Chelis L, Vardakis N, Vamvakas L, Georgoulias V, Kakolyris S.
  Lung Cancer. 2010 Jun;68(3):450-4. doi: 10.1016/j.lungcan.2009.08.012. Epub 2009 Sep 23.
  PMID: 19783319 [PubMed - indexed for MEDLINE]
  Similar articles
  Continuous administration of daily low-dose temozolomide in pretreated patients with advanced non-small cell lung cancer: a phase II study.
  Kouroussis C, Vamvakas L, Vardakis N, Kotsakis A, Kalykaki A, Kalbakis K, Saridaki Z, Kentepozidis N, Giassas S, Georgoulias V.
  Oncology. 2009;76(2):112-7. doi: 10.1159/000192586. Epub 2009 Jan 14.
  PMID: 19142045 [PubMed - indexed for MEDLINE]
  Similar articles
  Pooled analysis of elderly patients with non-small cell lung cancer treated with front line docetaxel/gemcitabine regimen: the Hellenic Oncology Research Group experience.
  Pallis AG, Polyzos A, Boukovinas I, Agelidou A, Lamvakas L, Tsiafaki X, Agelidou M, Pavlakou G, Chandrinos V, Kakolyris S, Christophyllakis C, Kentepozidis N, Giassas S, Androulakis N, Agelaki S, Georgoulias V.
  J Thorac Oncol. 2008 May;3(5):505-10. doi: 10.1097/JTO.0b013e31816b4b32.
  PMID: 18449003 [PubMed - indexed for MEDLINE] Free Article
  Similar articles
  A dose escalation study of the biweekly administration of paclitaxel, oxaliplatin and capecitabine in patients with advanced solid tumors.
  Saridaki Z, Bozionelou V, Kentepozidis N, Kotsakis A, Vardakis N, Kalykaki A, Gioulbasanis I, Karampeazis A, Vamvakas L, Georgoulias V, Mavroudis D.
  Oncology. 2007;72(1-2):45-50. Epub 2007 Nov 12. Erratum in: Oncology. 2007;73(5-6):406. Karabeazis, Athanasios [corrected to Karampeazis, Athanasios].
  PMID: 17998790 [PubMed - indexed for MEDLINE]
  Similar articles
  A dose escalation study of biweekly oral vinorelbine and gemcitabine in patients with solid tumors.
  Karampeazis A, Vamvakas L, Agelaki S, Kentepozidis N, Papadimitraki E, Gioulbasanis I, Vardakis N, Ignatiadis M, Mavroudis D, Georgoulias V.
  Oncology. 2006;71(5-6):347-53. Epub 2007 Sep 3.
  PMID: 17785992 [PubMed - indexed for MEDLINE]
  Similar articles
  Dose escalating clinical study of high dose infusional 5-fluorouracil and leukovorin (AIO regimen) plus alternate weekly administration of oxaliplatin and irinotecan in patients with advanced tumors of the gastrointestinal tract.
  Gkioulbasanis I, Souglakos J, Vardakis N, Kotsakis A, Saridaki Z, Kentepozidis N, Polyzos A, Giassas S, Ignatiadis M, Bozionelou V, Christophylakis C, Georgoulias V.
  J BUON. 2007 Apr-Jun;12(2):197-202.
  PMID: 17600872 [PubMed - indexed for MEDLINE]
  Similar articles
  A dose escalation and pharmacokinetic study of biweekly pegylated liposomal doxorubicin, paclitaxel and gemcitabine in patients with advanced solid tumours.
  Bozionelou V, Vamvakas L, Pappas P, Agelaki S, Androulakis N, Kalykaki A, Nikolaidou M, Kentepozidis N, Giassas S, Marselos M, Georgoulias V, Mavroudis D.
  Br J Cancer. 2007 Jul 2;97(1):43-9. Epub 2007 Jun 5.
  PMID: 17551496 [PubMed - indexed for MEDLINE] Free PMC Article
  Similar articles
  In vitro postantibiotic effect of colistin on multidrug-resistant Acinetobacter baumannii.
  Plachouras D, Giamarellos-Bourboulis EJ, Kentepozidis N, Baziaka F, Karagianni V, Giamarellou H.
  Diagn Microbiol Infect Dis. 2007 Apr;57(4):419-22. Epub 2006 Dec 22.
  PMID: 17188449 [PubMed - indexed for MEDLINE]
  Similar articles
  Oxaliplatin as first-line treatment in inoperable biliary tract carcinoma: a multicenter phase II study.
  Androulakis N, Aravantinos G, Syrigos K, Polyzos A, Ziras N, Tselepatiotis E, Samonis G, Kentepozidis N, Giassas S, Vamvakas L, Georgoulias V.
  Oncology. 2006;70(4):280-4. Epub 2006 Oct 12.
  PMID: 17047399 [PubMed - indexed for MEDLINE]
  Similar articles
  Pegylated liposomal doxorubicin in combination with vinorelbine as salvage treatment in pretreated patients with advanced breast cancer: a multicentre phase II study.
  Ardavanis A, Mavroudis D, Kalbakis K, Malamos N, Syrigos K, Vamvakas L, Kotsakis A, Kentepozidis N, Kouroussis C, Agelaki S, Georgoulias V; Breast Cancer Committee of the Hellenic Oncology Research Group.
  Cancer Chemother Pharmacol. 2006 Dec;58(6):742-8. Epub 2006 May 23.
  PMID: 16718470 [PubMed - indexed for MEDLINE]
  Similar articles
  A multicenter phase II study of sequential vinorelbine and cisplatin followed by docetaxel and gemcitabine in patients with advanced non-small cell lung cancer.
  Pallis AG, Agelidou A, Papakotoulas P, Tsaroucha A, Agelidou M, Agelaki S, Androulakis N, Vamvakas L, Gerogianni A, Kotsakis A, Kentepozidis N, Georgoulias V.
  Lung Cancer. 2006 May;52(2):165-71. Epub 2006 Mar 24.
  PMID: 16563559 [PubMed - indexed for MEDLINE]
  Similar articles
  Phase I study of weekly docetaxel and liposomal doxorubicin in patients with advanced solid tumors.
  Kouroussis Ch, Androulakis N, Vamvakas L, Kalykaki A, Spiridonakou S, Kentepozidis N, Saridaki Z, Xiropoulou E, Georgoulias V.
  Oncology. 2005;69(3):202-7. Epub 2005 Aug 26.
  PMID: 16127289 [PubMed - indexed for MEDLINE]
  Similar articles
  Front-line treatment of advanced non-small cell lung cancer with irinotecan and docetaxel: a multicentre phase II study.
  Ziotopoulos P, Androulakis N, Mylonaki E, Chandrinos V, Zachariadis E, Boukovinas I, Agelidou A, Kentepozidis N, Ignatiadis M, Vossos A, Georgoulias V; Lung Cancer Committee of the Hellenic Oncology Research Group (HORG).
  Lung Cancer. 2005 Oct;50(1):115-22.
  PMID: 15993981 [PubMed - indexed for MEDLINE]
  Similar articles
  Postantibiotic effect of antimicrobial combinations on multidrug-resistant Pseudomonas aeruginosa.
  Giamarellos-Bourboulis EJ, Kentepozidis N, Antonopoulou A, Plachouras D, Tsaganos T, Giamarellou H.
  Diagn Microbiol Infect Dis. 2005 Feb;51(2):113-7.
  PMID: 15698716 [PubMed - indexed for MEDLINE]
  Similar articles
  A multicenter phase II study of the combination of gemcitabine and docetaxel in previously treated patients with small cell lung cancer.
  Agelaki S, Veslemes M, Syrigos K, Palamidas F, Polyzos A, Papakotoulas P, Kentepozidis N, Milaki G, Tzanakis N, Kouroussis C, Vamvakas L, Georgoulias V; Hellenic Oncology Research Group.
  Lung Cancer. 2004 Mar;43(3):329-33.
  PMID: 15165092 [PubMed - indexed for MEDLINE]
  Similar articles

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Έχει διαβαστεί 1512 φορές

Ημερολόγιο

Ογκολόγοι Κεντεποζίδης

ΓΡΗΓΟΡΗ ΕΠΙΚΟΙΝΩΝΙΑ

Ογκολόγοι Δρ. Ν. Κεντεποζίδη

Βασ. Σοφίας 102, Αθήνα 11527

Τηλ. Ιατρείου    +30 210 7258409

Τηλ. Ραντεβού  +30 6970039500